President and CEO Kevin Sayer said the company will file for Medicare coverage of the G6, while it continues to work out an issue that prevents beneficiaries from using a feature that lets data be ...
Investors misunderstand DXCM's recent revenue growth as a function of significant user adoption. Our research suggests one-off pre-buying of extendable sensors ahead of a big price increase. DXCM is ...
Dexcom has received approval in Europe extending the use of its wearable continuous glucose monitor (CGM) to pregnant women across Type 1, Type 2 and gestational diabetes. Blood sugar levels can be ...
DUBLIN, Feb. 3, 2020 /PRNewswire/ -- The "Diabetes Management: Blood Glucose Monitoring Devices Market" report has been added to ResearchAndMarkets.com's offering. Valued at nearly $8bn in 2018, the ...
Wider use of the Dexcom G6 real-time continuous glucose monitoring (RT-CGM) system in the United Kingdom would be cost-effective in the long term, new research suggests. The analysis was published in ...
The FDA on Tuesday approved the use of a professional continuous glucose monitoring system from Dexcom, according to a press release from the company. Glucose measures are tracked for 10 days with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback